News
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Edgewise Therapeutics shares tumbled more than 20% Wednesday after the developmental drug company issued the results of its ...
6don MSN
Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...
Sarepta Therapeutics said a patient taking its treatment for Duchenne muscular dystrophy has died from acute liver failure.
Early in 2024, WeightWatchers lost its most prominent board member, Oprah Winfrey, when the media mogul announced her ...
27-year-old Dylan Jakub Davis was released without bail following his arraignment on first-degree drug sales and possession ...
The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.
When police found a mobile phone in a gutter while attending an incident they decided to check it for criminal behaviour - ...
2h
Zacks Investment Research on MSNHims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play itHims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are much ...
In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.
However, the stock has been under pressure due to disappointing data from two late-stage studiesfor its next-generation subcutaneous obesity candidate, CagriSema, a follow-up drug to Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results